Accelerating Drug Discovery with Eli Lilly’s TuneLab
- TuneLab provides access to Eli Lilly-trained AI models to help accelerate breakthrough medicines to patients
- The platform employs federated learning, a privacy-preserving approach that enables biotechs to tap into Eli Lilly’s AI models without directly exposing their proprietary data
- Learn how to become a participant in this first-of-its-kind, collaborative AI/ML drug discovery platform